Fintel reports that on December 11, 2025, HC Wainwright & Co. maintained coverage of Nuvation Bio (NYSE:NUVB) with a Buy ...

We recently published 10 Stocks Stealing Market Spotlight. Nuvation Bio Inc. (NYSE:NUVB) is one of the best performers on ...

Fintel reports that on December 1, 2025, HC Wainwright & Co. reiterated coverage of Nuvation Bio (NYSE:NUVB) with a Buy ...

Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced the publication of positive results from a Phase 2 ...

Nuvation Bio (NUVB) shares have caught investor attention following recent trading activity that pushed the stock up more than 50% over the past month. The move has sparked new conversations about the ...

Live webcasts of each fireside chat will be available on the Investor Relations section of the Nuvation Bio website. An archived recording will be available for 90 days following each event. Nuvation ...

In recent news, Nuvation Bio announced it will discontinue the development of NUV-1511, its initial drug-drug conjugate candidate, due to inconsistent efficacy and will redirect resources to other ...

Citi Annual Global Healthcare Conference 2025 December 3, 2025 9:00 AM ESTCompany ParticipantsDavid Hung - Founder, President, ...

Nuvation Bio stock is downgraded as price reflects Ibtrozi’s strong launch. Get insights on NUVB stock's forward revenue and investor strategies.

Following these transactions, Liu directly owns 18,000 shares of Nuvation Bio Inc. In other recent news, Nuvation Bio Inc. reported its third-quarter 2025 earnings, significantly surpassing ...

Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief ...

Detailed price information for Nuvation Bio Inc (NUVB-N) from The Globe and Mail including charting and trades.